Business Review

Gross Revenue and Average
Revenue per Occupied Bed*

Revenue growth was impacted due to some carryover of Max Shalimar Bagh disruption and turbulence in the international markets.

EBIDTA and
EBIDTA Margin

Sharp improvement in EBITDA and EBITDA Margins due to structural cost optimisation which drove efficiencies.

Revenue Split (%)

Oncology witnessed the highest growth owing to clinician hiring, technology improvement and increasing patient loyalty and confidence.

Bed Occupancy

After a low occupancy of 70.9% in Q1 FY2019 due to international factors and clinician exits in Max Mohali and Max Smart, occupancy improved to 76.0% in Q4 FY2019, increasing the annual Occupancy Ratio.

Gross Written Premium

GWP increase has been due to healthy growth in new sales as well as renewals.

Lives in Force*

Healthy growth in customer base, driven by a multi-channel distribution strategy.

B2C Claims Ratio (%)

Healthier Claims Ratio achieved primarily through focus on retail business and strengthening underwriting and fraud prevention controls.

Premium Per Life

Consistent growth in Average Premium Per Life, driven by higher sum assured penetration across customer segments.